Chemistry:Intetumumab

From HandWiki
Short description: Monoclonal antibody
Intetumumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targetintegrin alpha-V
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6468H10008N1744O2006S40
Molar mass145579.81 g·mol−1
 ☒N☑Y (what is this?)  (verify)

Intetumumab is a human monoclonal antibody targeting integrins[1] that was being studied for the treatment of solid tumors.[2]

Intetumumab was developed by Centocor, Inc.

Phase II clinical trials for treatment of melanoma and prostate cancer were in progress when development of the drug was discontinued.[3]

References

  1. "Integrins as A New Target for Cancer Treatment". Anti-Cancer Agents in Medicinal Chemistry 19 (5): 580–586. 2019. doi:10.2174/1871520618666181119103413. PMID 30451118. 
  2. "Statement On A Nonproprietary Name Adopted By The USAN Council: Intetumumab". American Medical Association. http://www.ama-assn.org/ama1/pub/upload/mm/365/intetumumab.pdf. 
  3. "Intetumumab". http://adisinsight.springer.com/drugs/800019252.